title: [Urapidil effects on oxidative stress in hypertensive crises].
abstract: Urapidil effects on oxidant stress were studied in 36 patients with hypertension stage I-III running with crises. Acute hypertensive crisis was managed by intravenous injections of urapidil (20-50 mg) for 5 min. After that for a week they received urapidil monotherapy followed by combined treatment for another week (quinapril--25 mg/day or ramipril--5-10 mg/day in combination with hypothiaside--25 mg/day; lokren--20 mg/day or atenolol--50-100 mg/day and diltiazem--180-360 mg/day) to stabilize arterial pressure finally. Oxidant stress was estimated by lipid peroxidation (LPO) and state of antioxidant system (AOS). Catabolism and anabolism were evaluated by blood levels of hydrocortisone and insulin. LPO, AOS, the blood hormones were measured before management of hypertensive crisis, immediately after it and 1, 3, 7 and 14 days after. Before the crisis treatment LPO was found high. Urapidil administration reduced levels of hydrocortisone, dienic conjugates, lipid peroxidation, oxidant stress rate (OSR). Later, LPO and OSR slowly increased. It is concluded on validity of the antioxidants use in hypertensive patients with crises.
authors.forename: P P
authors.initials: PP
authors.lastname: Golikov
authors.forename: B V
authors.initials: BV
authors.lastname: Davydov
authors.forename: V V
authors.initials: VV
authors.lastname: Marchenko
authors.forename: N Iu
authors.initials: NIu
authors.lastname: Nikolaeva
authors.forename: A P
authors.initials: AP
authors.lastname: Golikov
authors.forename: V A
authors.initials: VA
authors.lastname: Riabinin
authors.forename: E V
authors.initials: EV
authors.lastname: Semenova
authors.forename: V Iu
authors.initials: VIu
authors.lastname: Polumiskov
mesh_terms: D000208:Acute Disease; D000328:Adult; D000368:Aged; D000959:Antihypertensive Agents / Q000008:administration & dosage*; D001794:Blood Pressure / Q000187:drug effects; D006801:Humans; D006973:Hypertension / Q000188:drug therapy / Q000378:metabolism*; D007275:Injections, Intravenous; D015227:Lipid Peroxidation / Q000187:drug effects / Q000502:physiology; D008875:Middle Aged; D009569:Nitric Oxide / Q000502:physiology; D018384:Oxidative Stress / Q000187:drug effects*; D010879:Piperazines / Q000008:administration & dosage*
chemical_list: D000959:Antihypertensive Agents; D010879:Piperazines; D009569:Nitric Oxide; C015568:urapidil